Deal of the Day — limited-time pharmacy picks!
Inbec Tablet

Inbec Tablet

Prescription requiredRx Required

Salt Composition: Abacavir, Dolutegravir and Lamivudine

Expiry Date: 01/2028

Special offer

Buy at $94.71

$94.71

Inclusive of all taxes

▼

30 tablet

About The Product

HIV

Inbec tablet (Indinavir) is an antiretroviral or antiviral medicine. It is a prescription-based medicine used for the treatment of HIV (Human Immunodeficiency Virus) infection. This medicine is not a cure for HIV or AIDS, but it helps reduce the symptoms of the disease by decreasing the virus in the blood. Inbec tablet interferes with an enzyme (protease), which is required by HIV-infected cells to make new viruses.

It stops or slows the virus from multiplying. It is advisable to take this medicine exactly as prescribed by the doctor for better efficacy without increasing or decreasing the dose strength. Inbec tablet is a combination of three antiviral medications: Lamivudine, Abacavir, and Dolutegravir. They work together in preventing the multiplication of viruses in human cells.

Uses

Treatment of HIV infection

Side Effects

The human body reacts differently to the Inbec tablet. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.

Some of the common side effects of Inbec tablet are mentioned below:

  • Headache
  • Blood in urine
  • Skin rash
  • Itching
  • Vomiting
  • Nausea
  • Diarrhea
  • Dizziness
  • Drowsiness
  • Hair loss
  • Fatigue

How To Use

  • Take the dose of Inbec tablet as per your healthcare provider’s prescription.
  • Do not stop taking the medicine suddenly, unless your doctor tells you.
  • This medicine is given under the strict supervision of a doctor.
  • Do not self-administer.
  • Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider.
  • Inbec tablet can be taken without food or with food.
  • The doctor will provide emergency medical treatment.
  • You should not break, crush, or chew the medicine; it should be swallowed as a whole.

How It Works

  • Inbec tablet contains Indinavir, which is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). These inhibitors block the part of HIV called protease.
  • HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1.
  • Indinavir works to bind to the protease active site and inhibits the activity of the enzyme. Further, this inhibition prevents cleavage of the viral polyproteins, resulting in the formation of an immature non-infectious viral particle.

Safety Advice

Alcohol
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking the Inbec tablet. Consult your doctor for further information.
Pregnancy
The Inbec tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking the Inbec tablet during pregnancy has shown harmful effects on the developing baby.
Breast Feeding
The Inbec tablet is probably not safe if you're breastfeeding. Kindly consult your doctor before taking the Inbec tablet while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.
Driving
It is advisable not to drive or operate heavy machinery after taking the Inbec tablet, as you may feel dizzy.
Kidney
Share your medical history with your healthcare expert in case of kidney disease before taking the Inbec tablet. Patients with renal impairment must be careful while taking the Inbec tablet. They may require adjustment in the dose.
Liver
Inform your doctor before starting the Inbec tablet if you have liver disease to avoid any serious side effects. Patients with hepatic impairment must be careful while taking the Inbec tablet. They may require adjustment in the dose.

Missed Doses

  • It is advisable to not skip a dose.
  • If you miss a dose, make sure to take it as soon as you remember.
  • However, if it is already time for your next scheduled dose, skip the missed dose and take the scheduled dose.
  • Also, make sure to not increase the dose strength to catch up with the missed dose.

FAQs

Inbec (Indinavir) capsule is a prescription medicine, used in the treatment of HIV (Human Immunodeficiency Virus) infection.

It interferes with an enzyme (protease), which is required by HIV-infected cells to make new viruses.

Reference

  • Gazzard B, Moecklinghoff C, Hill A. (2025).  New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom. Clinicoecon Outcomes Res. 4:193–200 - https://pubmed.ncbi.nlm.nih.gov/22888265/
  • Kaufmann D, Pantaleo G, Sudre P, Telenti A. (2024). CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet. 351(9104):723–4 - https://pubmed.ncbi.nlm.nih.gov/9504519/
  • Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, et al. (2024). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Italy, the Netherlands, Canada and Australia study. JAMA. 279(12):930–7.
  • Olalla J, Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J. (2025). Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks. BMC Pharmacol Toxicol.19(1):63 - https://pubmed.ncbi.nlm.nih.gov/31272264/
  • Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J, Olalla J. (2025). Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks. Infect Dis (Lond). 51(9):691-693 - https://pubmed.ncbi.nlm.nih.gov/31272264/
  • Walmsley S, Baumgarten A, Berenguer J, Felizarta F, Florence E, Khuong-Josses MA, Kilby JM, Lutz T, Podzamczer D, Portilla J, Roth N, Wong D, Granier C, Wynne B, Pappa K. (2025). Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial. J Acquir Immune Defic Syndr. 70(5):515-9 - https://pubmed.ncbi.nlm.nih.gov/26262777/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026